Resmed (RMD) Cash from Financing Activities (2009 - 2026)
Resmed (RMD) posted Cash from Financing Activities of -$255.2 million for Q1 2026, up 1.2% on a QoQ basis from -$258.3 million in Q4 2025, and down 77.16% year-over-year from -$1.1 billion in Q1 2025.
Resmed (RMD) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Resmed's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$255.2 million for Q1 2026.
- Quarterly Cash from Financing Activities fell 77.16% year-over-year to -$255.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$907.8 million (down 8.63% YoY) and the FY2025 annual result came in at -$606.3 million, up 45.84% from the prior year.
- Cash from Financing Activities was -$255.2 million for Q1 2026 at Resmed, up from -$258.3 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $932.9 million in Q4 2022 and bottomed at -$393.3 million in Q2 2024.
- A 5-year average of -$120.6 million and a median of -$163.9 million in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 527.99% — and 2023, when it sank 427.99%.
- Resmed's Cash from Financing Activities stood at $932.9 million in 2022, then tumbled by 125.61% to -$239.0 million in 2023, then soared by 38.26% to -$147.5 million in 2024, then tumbled by 75.11% to -$258.3 million in 2025, then rose by 1.2% to -$255.2 million in 2026.
- Business Quant data shows RMD's Cash from Financing Activities at -$255.2 million in Q1 2026, -$258.3 million in Q4 2025, and -$230.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255.24 Mn |
| Mar 31, 2026 | -255.24 Mn |
| Dec 31, 2025 | -258.35 Mn |
| Dec 31, 2025 | -258.35 Mn |
| Sep 30, 2025 | -230.27 Mn |
| Sep 30, 2025 | -230.27 Mn |
| Jun 30, 2025 | -163.89 Mn |
| Jun 30, 2025 | -163.89 Mn |
| Mar 31, 2025 | -144.07 Mn |
| Mar 31, 2025 | -144.07 Mn |
| Dec 31, 2024 | -147.54 Mn |
| Dec 31, 2024 | -147.54 Mn |
| Sep 30, 2024 | -150.76 Mn |
| Sep 30, 2024 | -150.76 Mn |
| Jun 30, 2024 | -393.28 Mn |
| Jun 30, 2024 | -393.28 Mn |
| Mar 31, 2024 | -335.91 Mn |
| Mar 31, 2024 | -335.91 Mn |
| Dec 31, 2023 | -238.96 Mn |
| Dec 31, 2023 | -238.96 Mn |